Why is Jubilant Pharmo falling/rising?

As of 29-Aug, Jubilant Pharmova Ltd's stock price is currently at 1,023.80, reflecting a decrease of 12.2 points or 1.18%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.47% over the past week. Additionally, it has touched an intraday low of Rs 1012.75, indicating a significant drop. Despite these recent declines, the company has shown positive financial performance, with a reported profit after tax growth of 22.90% over the last six months and a low debt-equity ratio of 0.44 times. The stock is trading at a discount compared to its peers, and its attractive valuation is supported by a PEG ratio of 0.8. However, the recent price movement suggests that investor sentiment may be cautious despite the company's strong fundamentals.
In the broader market context, Jubilant Pharmova's short-term performance has been notably weaker than the benchmark, with a 1-week return of -5.47% compared to the Sensex's decline of only -1.84%. This underperformance is further highlighted by the stock's negative returns over the past month, where it has decreased by 11.59%, while the Sensex has only dropped by 1.88%. The rising investor participation, indicated by a 16.1% increase in delivery volume, suggests some interest in the stock, but overall market conditions and the stock's recent performance indicate a challenging environment for Jubilant Pharmova at this time.